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ABSTRACT 
Globally, approximately 10-25% of women smoke during pregnancy. Since nicotine is highly 
addictive, women may use nicotine containing products like nicotine replacement therapies for 
smoking cessation, but the long-term consequences of early life exposure to nicotine remain 
poorly defined.  Our laboratory has previously demonstrated that maternal nicotine exposed 
(MNE) rat offspring exhibit hypertriglyceridemia due to increased hepatic de novo lipogenesis. 
Hypertriglyceridemia may also be attributed to impaired white adipose tissue (WAT) lipid 
storage; however, the effects of MNE on WAT are not completely understood. We hypothesize 
that nicotine-induced alterations in adipose function (e.g. lipid storage) underlie dyslipidemia in 
MNE adults. Female 6 month old rats exposed to nicotine during gestation and lactation 
exhibited significantly decreased visceral adipocyte cell area by 40%, attributed, in part, to a 3-
fold increase in adipose triglyceride lipase (ATGL) protein expression compared to vehicle. 
Given ATGL has antioxidant properties and in utero nicotine exposure promotes oxidative stress 
in various tissues, we next investigated if there was evidence of increased oxidative stress in 
MNE WAT. At both 3 weeks and 6 months, MNE offspring expressed 37-48% higher protein 
levels of SOD1 and SOD2 in WAT. Since oxidative stress can induce inflammation, we 
examined the inflammatory profile of WAT and found increased expression of cytokines (IL-1β, 
TNFα, and IL-6) by 44-61% at 6 months. Collectively, this suggests that the expression of WAT 
ATGL may be induced to counter MNE-induced oxidative stress and inflammation. However, 
higher levels of ATGL would further promote lipolysis in WAT, culminating in impaired lipid 
storage and long-term dyslipidemia. 
 
KEY WORDS: White adipose tissue, maternal nicotine exposure, oxidative stress, adipocytes 
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INTRODUCTION 
Evidence now demonstrates that cigarette smoke plays a critical role in the development 
of dyslipidemia and obesity in children exposed during perinatal life (Wen et al., 2010;  Weng et 
al., 2012). This is especially concerning given that approximately 10-25% of women still smoke 
during pregnancy, with rates as high as 59% in certain Indigenous communities (Cui et al., 2014;  
Roman-Galvez et al., 2017;  Tappin et al., 2010;  Tong et al., 2013). To date, nicotine 
replacement therapies (NRT) for smoking cessation (i.e. transdermal patches, gums, e-cigarettes) 
are thought to benefit pregnant women who are highly addicted and unable to quit smoking by 
other means (Oncken and Kranzler, 2003). However, the consequences of fetal and neonatal 
exposure to nicotine alone on the long-term metabolic health of the offspring have yet to be fully 
defined.   
 Maternal nicotine use during gestation and lactation leads to significant exposure to the 
fetus and neonate since it is present in fetal blood and transferred through amniotic fluid, 
placental tissue, and breast milk (Luck and Nau, 1987;  Luck et al., 1985). Numerous animal 
studies demonstrate that nicotine use during pregnancy leads to adverse neurobehavioral, 
pulmonary, cardiovascular, and metabolic outcomes in the offspring  (Barra et al., 2017;  Chou 
and Chen, 2014;  Dasgupta et al., 2012;  Ma et al., 2014;  Pauly and Slotkin, 2008). Specifically, 
we and others have shown in rats that perinatal exposure to nicotine alone leads to increased 
blood pressure, adiposity, decreased glucose tolerance, and impaired pancreatic beta cell 
development (Fox et al., 2012;  Gao et al., 2008;  Gao et al., 2005;  Holloway et al., 2008). 
Moreover, MNE during gestation and lactation leads to increased hepatic de novo lipogenesis 
and increased hepatic and circulating triglycerides in postnatal life (Ma et al., 2014). This 
reciprocates human studies which have demonstrated that children exposed to maternal smoke in 
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utero have higher triglyceride levels later in life (Cupul-Uicab et al., 2012). Since increased 
circulating plasma triglycerides is strongly associated with cardiovascular disease (CVD) (Bansal 
et al., 2007), elucidating the underlying molecular mechanisms promoting dyslipidemia will 
undoubtedly uncover therapeutic targets to reduce unwarranted CVD risk to these nicotine-
exposed individuals.  
Aside from the liver, the augmented circulating and hepatic triglyceride accumulation 
observed in these MNE offspring could also be attributed to impairments in other metabolic 
tissues, such as white adipose tissue (WAT). The major role of WAT  is to store excess 
circulating triglycerides to prevent glucose and lipid toxicity, and moreover, ectopic fat 
deposition (Abate, 2012). Excess circulating triglycerides promote adipocytes to undergo 
differentiation, hypertrophy, and/or hyperplasia to process and store lipids. Once the maximum 
triglyceride storage capacity is reached, fatty acids can spillover in the plasma, increasing 
substrate availability for hepatic triglyceride synthesis (Abate, 2012). Ultimately, 
hypertriglyceridemia contributes to various systemic abnormalities like dyslipidemia, insulin 
resistance, and CVD (Abate, 2012). Currently, the effects of MNE on white adipose tissue 
function are not completely understood. Studies by Somm et al. indicated that MNE during 
gestation resulted in adipocyte hypertrophy and increased expression of adipogenic transcription 
factors in 3 week male offspring, but the long-term effects were not examined (Somm et al., 
2008). A more recent study by Fan et al. (2016) demonstrated that maternal exposure of nicotine 
(from gestational day 9 to weaning) led to decreased adipocyte size in 26 week old male 
offspring, suggesting an impaired capacity for lipid storage. Furthermore, this study also found 
an increase in steady-state mRNA levels of adipocyte differentiation and lipogenic markers in 
MNE WAT compared to vehicle (Fan et al., 2016). However, given most women addicted to 
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smoking would be exposed to nicotine (i.e. NRT or cigarettes) in both prenatal and perinatal life, 
the goal of this study was to determine if this longer, more relevant, window of nicotine exposure 
impacts adipose function in both male and female offspring. Moreover, this window covers the 
entire period of rat adipose tissue differentiation (Greenwood and Hirsch, 1974). We hypothesize 
that in utero nicotine exposure will adversely impact WAT in the offspring, leading to 
dyslipidemia in adulthood.  To examine this further, we will investigate if WAT function is 
affected due to altered adipocyte size, proliferation (i.e. Akt-1), differentiation (i.e. C/ebpα/β, 
Srebp-1c), lipogenesis (i.e. Lpl, Accα, Fas, Acsl1), fatty acid transport (i.e. Fatp1, Fatp4), and/or 
lipolysis (Atgl) in our well-established rat model of maternal nicotine exposure.  
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MATERIALS AND METHODS 
Maternal Nicotine Exposure (MNE) Rat Model   
Nulliparous 200-250g female Wistar rats (Harlan, Indianapolis, IN, USA) were injected 
daily subcutaneously with either saline (vehicle) or nicotine bitartrate at 1 mg/kg/day (Sigma-
Aldrich, St. Louis, MO, USA) two weeks prior to mating, during gestation, and until weaning 
(PND21). This nicotine dose results in maternal serum cotinine concentrations of 135.9±7.86 
ng/mL, which is comparable to “moderate” female smokers (80 ng/mL) or NRT users (169.9 
ng/mL) (Holloway et al., 2006;  Shahab et al., 2016). Litters were culled to eight at birth and 
following weaning, rats were housed as sibling pairs until 6 weeks of age, then subsequently 
housed individually. Male and female offspring were sacrificed via carbon dioxide inhalation at 
3 weeks and 6 months of age. Gonadal white adipose tissues were extracted, either fixed in 
formalin or frozen in liquid nitrogen and stored at -80°C for histological and molecular analyses, 
respectively. All rats were conventionally housed in polycarbonate microisolator cages with ad 
libitum access to water and standard chow diet (Teklad 22/5 rodent diet; Envigo) under 
controlled lighting (12:12 L:D), humidity (40-50%), and temperature (22˚C). In accordance with 
the Canadian Council for Animal Care guidelines, animal experiments were approved by the 
Animal Research Ethics Board at McMaster University. 
 
Gonadal Adipocyte Cell Area 
A portion of gonadal WAT was fixed in 10% (v/v) neutral buffered formalin overnight, washed 
in water, and embedded in paraffin. Cross sections were stained with hematoxylin and eosin 
(H&E) and photographed using the Olympus BX50 microscope under a 10x objective. Cell areas 
were quantified from a minimum of 160 adipocytes from two cross sections/rat using Northern 
Page 7 of 38 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Eclipse software (Empix Imaging Inc.).  
 
RNA Extraction and Real Time-Polymerase Chain Reaction (RT-PCR) 
Total RNA was extracted from homogenized 3 week and 6 month WAT samples using TRIzol 
reagent according to the manufacturer’s instructions (Invitrogen). Two micrograms of RNA were 
reversed-transcribed to cDNA (high-capacity cDNA Reverse Transcription Kit, Applied 
Biosystems). Forward and reverse primer sets used for RT-PCR, listed in Table 1, were designed 
with the National Center for Biotechnology Information’s primer designing tool. Relative 
transcript abundance was determined using SensiFAST No-ROX SYBR Green Supermix 
(FroggaBio) and the Bio-Rad CFX384 Real Time System. Samples were assayed in triplicate 
and relative fold change was calculated using comparative cycle times (Ct) method normalized 
to β-actin. The relative abundance was calculated using the formula 2
∆∆Ct
, where ∆∆Ct was the 
normalized value. 
Protein extraction and Western blot  
WAT was homogenized in RIPA buffer (50 mM Tris-HCL, pH 7.4, 150 mM NaCl, 1 mM 
EDTA, 1% Nonidet P40, 0.25% C24H39NaO4) supplemented with a protease inhibitor cocktail 
(Roche) and phosphatase inhibitors (20 mM NaF, 40mM Na-pyrophosphate, 40mM Na3VO4, 
200mM β-glycerophosphate disodium salt hydrate). The solution was sonicated, mixed in a 
rotator for 1hr at 4 °C, and centrifuged at 300g for 15 min at 4 °C. The total cellular protein 
extract in the collected supernatant was quantified by colorimetric DC protein assay (BioRad). 
Loading samples were heated at 50 °C for 10 min to denature the proteins. Proteins (20µg/well) 
were separated by size via gel electrophoresis and transferred onto polyvinylidene difluoride 
membrane (Millipore). Membranes were blocked in 1x Tris-buffered saline-Tween 20 buffer 
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with 5% non-fat milk or 5% BSA (blocking solutions), and then probed using primary antibodies 
diluted in the blocking solution (Table 2). A mouse or rabbit secondary antibody was used to 
detect primary antibody diluted in the blocking solution at 1:5,000 or 1:10,000 dilution, 
respectively (Table 2). Immuno-reactive bands were visualized, and relative band intensity was 
calculated using ImageLab software (BioRad) and normalized to β-actin, as previously 
performed (Ma et al., 2014).   
 
Statistical Analysis  
Statistical analyses were performed using Graphpad Prism 6 software. Results were 
presented as the mean of arbitrary values ± SEM. Grubbs’ test was used to determine significant 
outliers and data were tested for normality and equal variance. Comparisons between vehicle and 
nicotine exposed offspring were assessed using an unpaired Student’s t-test, with a p-value of 
less than 0.05 deemed as significant.  
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 RESULTS 
Maternal nicotine exposure leads to decreased visceral adipocyte size in 6 month old 
offspring. 
Using our well-established rat MNE model leading to dyslipidemia (Gao et al., 2005;  Ma et al., 
2014), we wanted to first confirm whether prenatal nicotine exposure has long term effects on 
adipocyte size in the offspring. Histological analyses revealed both MNE male and female 
offspring exhibited smaller gonadal adipocytes compared to vehicle controls at 6 months of age 
(Figure 1A, B). Given the more pronounced effects of perinatal nicotine exposure on female 
WAT area (13.2% male vs. 39.7% female decrease in adipocyte size), we continued to examine 
only female offspring to explore the underlying mechanisms involved. Gondal adipose tissue 
weight did not differ between MNE and vehicle offspring (data not shown), suggesting a 
possible increase in adipocyte number due to prenatal nicotine exposure. With decreased 
adipocyte cell area and subsequent increase in cell number, transcript and protein levels of the 
proliferation marker AKT-1 were subsequently measured. Despite a significant increase in 
mRNA levels, there were no corresponding changes in AKT-1 protein levels in 6 month female 
MNE WAT (Figure 1C, D). 
 
In utero nicotine exposure increases the expression of the differentiation marker C/EBPα in 
WAT of 6 month old female offspring. 
Given impairments in adipocyte differentiation can also decrease adipocyte size, we next 
measured the expression of key targets involved in adipogenesis (Abate, 2012), including 
CCAAT/enhancer-binding protein (C/EBP)-α/β and sterol regulatory element-binding 
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transcription factor (SREBP)-1c. Protein analyses revealed a significant increase in the 42kDa 
band of C/EBP-α in female MNE offspring compared to vehicle at 6 months independent of 
changes in transcript levels (Figure 2A, B). Quantitative real time PCR analyses revealed that 
WAT from MNE exposed offspring had a significant increase in steady-state transcript levels of 
C/EBPβ and SREBP-1c compared to controls (Figure 2C, E). However, immunoblot analyses 
revealed no significant differences at the protein level for either target (Figure 2D, F). To 
examine if perinatal nicotine exposure had direct effects on C/EBPα, we measured the transcript 
and protein levels at 3 weeks age but found no difference in expression from vehicle (Figure 2G, 
H).  
 
Maternal nicotine exposure does not increase the expression of markers involved in 
lipogenesis and fatty acid transporters in 6 month old female offspring. 
Adipocyte size is influenced by its ability to breakdown triglyceride (TG) molecules from 
circulation, transport its constitutive components intracellularly, and re-assemble TGs for storage 
(Kersten, 2014). Therefore, we wanted to determine whether perinatal nicotine exposure 
impaired triglyceride transport and esterification by measuring the steady state transcript levels 
of key targets involved in lipogenesis and fatty acid transport. At six months of age we found no 
significant difference between groups in the expression of lipogenic markers including 
lipoprotein lipase (LPL), acetyl-coA carboxlyase (ACCα), and fatty acid synthase (FAS), along 
with fatty acid transporters FATP1/4, and long-chain acyl CoA synthetase (ASCL)-1 in female 
MNE WAT (Figure 3A-F).  
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In utero nicotine exposed female offspring exhibit increased expression of ATGL at 6 
months, but not at 3 weeks. 
Since enhanced lipolysis decreases adipocyte size (Zhang et al., 2017), we then examined 
whether MNE WAT had elevated expression of adipose triglyceride lipase (ATGL), the 
predominate enzyme involved in intracellular degradation (Zechner et al., 2009). At six months 
of age, we found a significant increase in both ATGL mRNA expression and protein levels in 
nicotine exposed female WAT compared to vehicle controls (Figure 4A, B), however this was 
not observed at 3 weeks (Figure 4C-D). Altogether, these data suggest that augmented ATGL-
induced lipolysis may lead to reduced adipocyte cell area in MNE WAT at 6 months. 
 
Maternal nicotine exposure exhibit enhanced anti-oxidant expression at 6 months and 3 
weeks. 
Evidence demonstrates that ATGL deficiency in mice is associated with accumulation of reactive 
oxygen species (ROS) and decreased SOD2 expression, suggesting this enzyme may act as an 
antioxidant and suppress oxidative stress (Aquilano et al., 2016;  Chen et al., 2017a;  Chen et al., 
2017b). Moreover, we and others have previously shown that maternal nicotine exposure 
promotes oxidative stress in the heart, pancreas, and placenta of adult offspring (Barra et al., 
2017;  Bruin et al., 2008;  Sbrana et al., 2011). Therefore, we wanted to determine whether an 
imbalance between antioxidant defenses occurs in WAT of 6 month female MNE offspring by 
measuring the transcript and protein levels of the antioxidants superoxide dismustase (SOD)-1 
and SOD-2. Both SOD 1 and 2 steady state mRNA and protein levels were significantly elevated 
in prenatal nicotine exposed WAT in 6 month female offspring compared to vehicle (Figure 5A-
D). At 3 weeks of age, there was also a significant increase in SOD-1 protein levels, and a 
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trending increase in SOD-2, in the nicotine exposed WAT group compared to controls (Figure 
5E-H). To determine if there was oxidative stress, we measured protein levels of 4-HNE and 
found a non-significant upward trend in nicotine-exposed WAT at both 3 week and 6 month 
timepoints (Figure 5I, 5J). Overall, these data suggest that prenatal nicotine exposure directly 
increase the expression of the antioxidant SOD-1 and SOD-2 in 6 month WAT which was 
enough to prevent lipid oxidative damage. 
 
In utero nicotine exposure exhibit inflammation at 6 months, but not at 3 weeks. 
Enhanced oxidative stress can activate nuclear factor-κB (NF-κB), leading the expression of pro-
inflammatory cytokines and inflammation (Li and Karin, 1999;  Morgan and Liu, 2011). As well, 
activation of this pathway in differentiated 3T3-L1 cells leads to increased lipase expression and 
lipolysis (Chi et al., 2014). Since oxidative stress, inflammation, and lipolysis are integrated 
pathways, we wanted to determine whether inflammation was present in 6 month in utero 
nicotine exposed WAT. At 6 months, we found a significant increase in the steady-state mRNA 
expression profile of pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin 
(IL)-1β, IL-6, and the macrophage marker CD68 (Figure 6A-D). In contrast at 3 weeks of age, 
there was no significant difference in steady state mRNA levels of inflammatory markers 
between groups (Figure 6E-H). 
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DISCUSSION 
 
Under normal physiological conditions, WAT serves as the principle lipid storage site to 
prevent ectopic lipid deposition in peripheral organs. The balance between lipolysis and 
lipogenesis dictates the overall amount of triglyceride molecules stored as a single large lipid 
droplet in the cytoplasm of adipocytes, ultimately influencing its size (Bolsoni-Lopes and 
Alonso-Vale, 2015). Adipocytes have a limited triglyceride storage capacity. Once exceeded, 
excess lipids will spill-over into circulation resulting in dyslipidemia and increased lipid content 
at ectopic sites like the liver (Abate, 2012). In our model, we have previously shown that MNE 
offspring have dyslipidemia with increased levels of circulating triglycerides (Gao et al., 2005;  
Ma et al., 2014). While we have shown that hepatic de novo lipogenesis is increased in nicotine-
exposed offspring, the effect of nicotine exposure on WAT function were not examined. 
Previous studies show maternal nicotine exposure during gestation or from gestation until 
weaning altered adipocyte size and increased the expression of adipocyte differentiation markers, 
but this was only examined in male offspring (Fan et al., 2016;  Somm et al., 2008). Moreover, 
this exposure to nicotine in these studies (gestation only or mid-gestation to weaning only) does 
not mimic women’s smoking habits and/or nicotine use prior to pregnancy. Therefore, our goal 
was to determine if WAT plays a role in promoting dyslipidemia in both male and female 
offspring exposed to nicotine in prenatal and perinatal life. 
 In this study, we demonstrated that both male and female offspring exposed to nicotine 
during prenatal and perinatal life decreased adipocyte cell area compared to vehicle controls at 6 
months of age. Somm et al. reported that rats exposed to nicotine during pregnancy alone (from 
gestational day 4 for 14 days at 3mg/kg/day) had adipocyte hypertrophy compared to vehicle 
controls in 3 week old male offspring, but the effect on WAT size into adulthood, after nicotine 
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exposure, was not examined (Somm et al., 2008). Similar to our findings, Fan et al. 
demonstrated that in utero nicotine exposure from mid-pregnancy (e.g. gestational day 9) until 
weaning decreased adipocyte size in male WAT at 26 weeks of age (Fan et al., 2016). The dose 
of nicotine (1 mg/kg) administered in this study is relevant as it corresponds to moderate female 
smokers or NRT users (Holloway, Kellenberger and Petrik, 2006;  Shahab et al., 2016), while 
doses used in other studies (2-3 mg/kg/day) correspond to heavy smokers (Fan et al., 2016;  
Somm et al., 2008). Examining the effects of MNE on WAT for a longer duration is important 
given adipose development occurs both pre- and postnatally in rats. In rodent adipose tissue, 
growth and differentiation occurs from late gestation to 4 weeks in postnatal life, while in 
humans this occurs from 5 to 29 weeks gestation (Greenwood and Hirsch, 1974;  Poissonnet et 
al., 1984). In both species, adipose tissue expansion happens throughout life (Greenwood and 
Hirsch, 1974;  Spalding et al., 2008). Given the extensive differentiation of adipose tissue during 
perinatal life, it is vulnerable to alterations by environmental cues (i.e. drugs) during this 
developmental window. Furthermore, both mature adipocytes and adipocyte precursors like 
mesenchymal stem cells express nicotinic acetyl-choline receptor subunits, suggesting that 
nicotine may directly alter adipogenesis and adipocyte formation (Gochberg-Sarver et al., 2012;  
Hoogduijn et al., 2009). 
Since the effect on adipocyte size was more pronounced in female offspring, and 
previous studies focused on males (Fan et al., 2016;  Somm et al., 2008), we decided to examine 
the effects of MNE on female adipose tissue function. One limitation of our study is that we did 
not evaluate the estrous cycle of the female rats. This is an important consideration since prenatal 
nicotine exposure increased progesterone levels in offspring compared to vehicle controls, which 
is reflective of estrous cycle perturbations (Holloway, Kellenberger and Petrik, 2006). 
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Furthermore, others have reported that oscillations in metabolic related genes in the liver occur 
with estrous cycle (Villa et al., 2012). Since small adipocyte size results from aberrant 
adipogenesis, we examined whether MNE impaired adipocyte differentiation, lipid synthesis and 
transport, and/or lipolysis. We found that female MNE offspring exhibited increased mRNA and 
protein expression of the adipocyte differentiation factor C/EBPα and the lipolytic enzyme 
ATGL, without altering the expression of targets involved in lipogenesis and lipid transport. 
Similar to our results, Fan et al. found an increased in steady-state mRNA levels of adipocyte 
differentiation markers in MNE male offspring, including C/EBPα and SREBP-1c compared to 
control WAT in adulthood (Fan et al., 2016). Since these studies did not perform protein 
analyses, our study is the first to demonstrate that MNE increased C/EBPα protein levels in 6 
month female WAT. Overall, the increased C/EBPα (42 kDa) expression in WAT suggests that 
MNE promote adipocyte differentiation and adipogenesis. C/EBPα contains two isoforms (30/42 
kDa) alternatively translated from one mRNA transcript (Lin et al., 1993;  Ossipow et al., 1993). 
Constitutive expression of the 42 kDa isoform can induce adipocyte differentiation in 3T3-L1 
preadipocytes, suggesting that enhanced C/EBPα expression of this isoform can enhance 
adipocyte formation (Lin and Lane, 1994).  While the steady-state levels of AKT1, C/EBP-α, 
SREBP 1c mRNA were augmented in 6 month nicotine-exposed offspring, this did not translate 
to an alteration in protein levels. There are several cases in the literature whereby changes in the 
mRNA levels do not correlate to an alteration in protein, highlighting the importance of looking 
at both mRNA and protein (Vogel and Marcotte, 2012).  Moreover, it is possible that the mRNA 
and protein levels of these key proliferation and differentiation markers may be altered earlier in 
development (i.e. gestation and/or lactation) due to the direct effects of nicotine on their 
expression. For example, we have demonstrated that nicotine directly enhances the expression of 
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the proliferation markers GADD45 and Rb1 in differentiating 3T3-L1 pre-adipocyte cells (data 
not shown). Therefore, in the absence of nicotine exposure after lactation, the levels of these 
proliferation and differentiation may have become normalized.  
This study was the first to demonstrate that both prenatal and perinatal nicotine exposure 
leads to increased ATGL mRNA and protein expression in adult female MNE offspring. This 
suggests that MNE may impair the lipid storage capacity of WAT via increased ATGL 
expression. Studies demonstrate that augmented ATGL leads to enhanced basal and stimulated 
WAT lipolysis and reduced adipocyte size (Ahmadian et al., 2009;  Bezaire et al., 2009;  
Kershaw et al., 2006). The primary function of ATGL is to initiate lipolysis, by hydrolyzing the 
sn-2 ester bond of a triglyceride molecule, resulting in the formation of diacylglycerol and fatty 
acid (Zechner et al., 2009). Therefore, decreased adipocyte cell size in gonadal WAT may be 
attributed to enhanced lipolysis in MNE offspring. 
Recently, evidence supports an additional role for ATGL - as an antioxidant and 
suppressor of oxidative stress. Oxidative stress is defined as an imbalance between antioxidant 
defenses and ROS production (free radicals) (Sena and Chandel, 2012). Prolonged oxidative 
stress can result in free radical damage, ultimately leading to mitochondrial-mediated apoptosis 
(Sena and Chandel, 2012). In vitro and in vivo analyses demonstrate that ATGL deficiency is 
associated with ROS accumulation and cellular apoptosis in renal podocytes and proximal 
tubules (Chen et al., 2017a;  Chen et al., 2017b). Similarly, ATGL inhibition in C2C12 
myoblasts and in murine ATGL deficient skeletal muscle promotes oxidative damage and a 
defective cellular antioxidant response, characterized by a significant reduction in antioxidant 
SOD-2 expression and glutathione levels (Aquilano et al., 2016). Altogether, these findings 
suggest that ATGL may protect against oxidative stress. We and others have previously shown 
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that maternal nicotine exposure can cause oxidative stress in the offspring in various tissues 
including the heart, pancreas, and placenta (Barra et al., 2017;  Bruin et al., 2008;  Sbrana et al., 
2011). Therefore, we examined the expression of antioxidants SOD-1/2 in WAT of 6 month 
female MNE offspring to assess whether an imbalance in anti-oxidant expression is present at the 
same time ATGL levels are elevated. Oxygen can oxidize other molecules to generate ROS, 
whereby majority of intracellular ROS are derived from superoxide (O2-). Superoxide is formed 
in the mitochondrial respiratory chain, emitted to the matrix and intermembrane space, and 
subsequently converted to hydrogen peroxide (H2O2) by superoxide dismutases (SODs) (Sena 
and Chandel, 2012). This study is the first to show that MNE WAT had increased transcript 
expression and protein levels of both SOD-1 and -2 at 6 months with evidence for increased 
SOD-1 at 3 weeks of age. Although non-significant, we also observed an upward trend for the 
oxidative marker 4-HNE in nicotine exposed WAT compared to vehicle at both time points. This 
suggests that perinatal nicotine exposure may instigate WAT oxidative stress, triggering a rapid 
increase in anti-oxidant expression by weaning which persists into adulthood and may prevent 
long-term oxidative damage.  
Oxidative stress can contribute to altered adipocyte differentiation and lipolysis. 
Depending on environmental cues, mesenchymal stem cells can differentiate into various cell 
types derived from the mesodermal lineage including myocytes, adipocytes, osteocytes, and 
chondrocytes. Evidence suggests that elevated ROS levels, produced during oxidative stress, can 
stimulate adipogenesis while suppressing osteogenesis (Atashi et al., 2015). During conversion 
of stem cells to adipocytes, mitochondrial complexes I/III and the NADPH oxidase isoform 
NOX4 produce ROS to initiate adipocyte signaling cascades, leading to terminal differentiation 
(Atashi, Modarressi and Pepper, 2015). Therefore, increased SOD-1 expression in fetal and 
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neonatal nicotine exposed WAT may suggest that augmented ROS production may directly 
promote the expression of adipogenic transcription factors like C/EBPα (Hu et al., 2005). In vitro 
analyses using both differentiated 3T3-L1 and human primary adipocyte cultures demonstrate 
that exposure to exogenous 4-HNE elevated lipolysis in basal and stimulated conditions 
characterized by a dose-dependent significant increase in glycerol and fatty acid release (Zhang 
et al., 2013). Altogether, these findings suggest that MNE may augment oxidative stress in WAT 
characterized by increased expression of antioxidants SOD-1/2 and ATGL, leading to altered 
adipocyte differentiation and lipolysis.  
Enhanced oxidative stress can promote pathways, like inflammation, that also influence 
adipose function. Exposure to hydrogen peroxide or ROS accumulation activates the 
transcription factor NF-κB, leading the expression of pro-inflammatory cytokines such as TNF-α 
or IL-1 (Lawrence, 2009;  Li and Karin, 1999;  Morgan and Liu, 2011). Intriguingly, treatment 
with either TNF-α or IL-6 in differentiated adipocytes can increase the expression of ATGL and 
enhance glycerol production (a marker of lipolysis). Moreover, in vitro studies reveal that TNF-α 
induces lipolysis in differentiated human and murine adipocytes through multiple distinct 
pathways (i.e. mitogen-activated protein kinase kinase, (MAPKK); extracellular signal-related 
kinase 1/2 (ERK); and elevation of cyclic adenosine monophosphate (cAMP); NH2-terminal 
kinase (JNK)) (Ryden et al., 2002;  Yang et al., 2011;  Zhang et al., 2002). Similarly, treatment 
with IL-6 induces lipolysis through increased expression of ATGL in soleus muscles ex vivo 
(Macdonald et al., 2013) and enhanced glycerol production in 3T3-L1 cells (Ji et al., 2011). Our 
results reveal that fetal and neonatal nicotine exposure culminates in increased steady-state 
mRNA levels of proinflammatory mediators, including TNF-α and IL-6 by 6 months of age. 
These results coincide with previous findings demonstrating that in utero nicotine exposure 
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resulted in increased circulating pro-inflammatory cytokines throughout development and in 11 
week old offspring (Mohsenzadeh et al., 2014;  Orellana et al., 2014). Since inflammation was 
present in 6 month female WAT and not at 3 weeks, this suggests that nicotine does not have a 
direct effect on inflammation but that augmented oxidative stress may mediate the expression of 
pro-inflammatory cytokines. One research group demonstrated that CD-1 mice fed a nicotine-
containing diet for 14 weeks postnatally decreased adipocyte cell size without affecting white 
adipose inflammation (Liu et al., 2018). In fact, treatment with 4-HNE in 3T3-L1 cells induced 
inflammation by activating p38, subsequently increasing the expression of cyclooxygenase-2 
(COX) (Zarrouki et al., 2007). Further studies are warranted to determine whether inflammation 
may in part promote lipolysis in prenatal nicotine exposed WAT long term. 
 In summary, our findings demonstrate that maternal nicotine exposure during pregnancy 
and lactation leads to decreased WAT adipocyte size and impaired lipid storage in postnatal life 
characterized by augmented lipolysis and inflammation triggered possibly by a pro-oxidative 
stress environment. This impairment in WAT lipid storage can contribute to increased circulating 
triglycerides, leading to enhanced hepatic de novo lipogenesis, high blood pressure, and 
increased CVD risk as we have previously shown (Gao et al. 2008;  Ma et al., 2014). These 
findings provide insight into the consequence of prolonged oxidative stress driving WAT 
dysfunction long-term. Postnatal intervention strategies targeting oxidative stress may benefit 
children exposed to nicotine in utero through cigarette smoke and/or NRT. In fact, studies 
demonstrate that the use of antioxidants (i.e. anthocyanin, quercetin, bottle gourd) can 
significantly reduce dyslipidemia (Li et al., 2015;  Talirevic and Jelena, 2012). Overall, results 
from this study suggests that therapeutic strategies targeting oxidative stress may effectively 
protect nicotine exposed offspring from WAT dysfunction and dyslipidemia. 
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FIGURE LEGENDS 
Figure 1: Maternal nicotine exposure leads to decreased visceral adipocyte cell area in 6 
month old offspring. Representative cross-sections of gonadal WAT excised from (A) vehicle 
and in utero nicotine exposed 6 month old male and female offspring were stained with 
hematoxylin and eosin. (B) Bar graph representing calculated cell areas analyzed using Northern 
Eclipse software (n=4/group/sex). (C) Transcript and (D) protein levels of AKT-1 in six month 
vehicle and perinatal nicotine exposed WAT were determined via real time PCR and Western 
blot, respectively. mRNA levels were expressed as means normalized to β-actin ± SEM 
(n=15/vehicle; n=11/nicotine). Protein levels were expressed as means normalized to β-actin ± 
SEM (n=8/vehicle; n=7/nicotine). **,*** Significant difference (**p<0.01, ***p < 0.001).  
 
Figure 2: In utero nicotine exposure increases the expression of the differentiation marker 
C/EBPα in WAT of 6 month old female offspring. Transcript and protein levels of targets of 
interest in 3 week and six month vehicle and perinatal nicotine exposed WAT were determined 
via real time PCR and Western blot, respectively. Six month (A) C/EBPα mRNA and (B) protein 
levels. (C) C/EBPβ mRNA and (D) protein levels. (E) SREBP1-c mRNA and (F) protein levels. 
Three week (G) C/EBPα mRNA and (H) protein levels. mRNA levels were expressed as means 
normalized to β-actin ± SEM (n=15/vehicle; n=11/nicotine). Protein levels were expressed as 
means normalized to β-actin ± SEM (n=8/vehicle; n=7/nicotine). *, Significant difference 
(*p<0.05).  
 
Figure 3: Maternal nicotine exposure does not increase the expression of markers involved 
in lipogenesis and fatty acid transporters in WAT of 6 month old female offspring. 
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Transcript levels of targets of interest in six month vehicle and perinatal nicotine exposed WAT 
were determined via real time PCR. Six month (A) LPL, (B) ACCα, (C) FAS, (D) ASCL1, (E) 
FATP1, and (F) FATP4 mRNA levels. mRNA levels were expressed as means normalized to β-
actin ± SEM (n=15/vehicle; n=11/nicotine).  
 
Figure 4: In utero nicotine exposed female offspring exhibit increased expression of ATGL 
at 6 months, but not at 3 weeks. Transcript and protein levels of ATGL in 3 week and six 
month vehicle and perinatal nicotine exposed WAT were determined via real time PCR and 
Western blot, respectively. Six month ATGL (A) mRNA and (B) protein levels. Three week 
ATGL (C) mRNA and (D) protein levels. mRNA levels were expressed as means normalized to 
β-actin ± SEM (n=15/vehicle; n=11/nicotine). Protein levels were expressed as means 
normalized to β-actin ± SEM (n=8/vehicle; n=8/nicotine). *,** Significant difference (*p<0.05, 
**p<0.01). 
 
Figure 5: In utero nicotine exposed female offspring exhibit increased anti-oxidant 
expression in WAT at 3 weeks and 6 months. Transcript and protein levels of SOD-1 and 
SOD-2 in 3 week and six month vehicle and perinatal nicotine exposed WAT were determined 
via real time PCR and Western blot, respectively. Six month SOD-1 (A) mRNA and (B) protein 
levels and SOD-2 (C) mRNA and (D) protein levels. Three week SOD-1 (E) mRNA and (F) 
protein levels and SOD-2 (G) mRNA and (H) protein levels. Protein levels of 4-HNE at (I) 6 
months and (J) 3 weeks of age. mRNA levels were expressed as means normalized to β-actin ± 
SEM (n=15/vehicle; n=11/nicotine). Protein levels were expressed as means normalized to β-
actin ± SEM (n=8/vehicle; n=8/nicotine). *,** Significant difference (*p<0.05, **p<0.01). 
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Figure 6: Maternal nicotine exposed female offspring exhibit increases in WAT 
inflammation at 6 months, but not at 3 weeks. Transcript levels of targets of interest in six 
month vehicle and perinatal nicotine exposed WAT were determined via real time PCR. Six 
month (A) IL-1β, (B) TNFα, (C) IL-6, and (D) CD68 mRNA levels. Three week (E) IL-1β, (F) 
TNFα, (G) IL-6, and (H) CD68 mRNA levels. mRNA levels were expressed as means 
normalized to β-actin ± SEM (n=15/vehicle; n=11/nicotine). *,**,*** Significant difference 
(*p<0.05, **p<0.01, **p<0.001). 
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 TABLES 
Table 1. Forward and reverse primer sequences used for quantitative Real-Time PCR 
GENE Forward  Reverse GenBank/Refer
ence 
AKT-1 ATGTGTATGAGAAGAAGC
TGAGCC 
GTTCACTGTCCACACACT
CCA 
NM_033230.2 
C/EBPα GCCGGGAGAACTCTAACT
CC 
TCGATGTAGGCGCTGATG
TC 
NM_00128757
7.1  
C/EBPβ ACCACGACTTCCTTTCCG
AC 
TAACCGTAGTCGGACGGC
TT 
NM_024125.5 
SREBP1
c 
CATGGACGAGCTACCCTT
CG 
TCTTCGATGTCGGTCAAG
AGC 
NM_00127670
7.1 
LPL GGATGCAACATTGGAGAA
CCC 
GCTGGGGTTTTCTTCATTC
AGC 
NM_012598.2 
ACCα TCCGTATGTGACCAAAGA
CC 
TACGTTGTTCCCAAGGAC
TG 
NM_022193.1  
FAS GGACATGGTCACAGACGA
TGAC 
CGTCGAACTTGGACAGAT
CCTT 
NM_017332.1  
ACSL1 CTACAGGCAACCCCAAAG
GA 
AATGCACTCTCCGTCGCT
T 
NM_012820.1 
FATP1 CAGCCTCTGTGGCCTCAT
T 
ACCCACGTACACACCGAA
C 
NM_053580.2  
FATP4 CTTGGGCAACTTTGACAG
CC 
AGGACAGGATGCGGCTAT
TG 
NM_00110070
6.1 
ATGL AACGCCACTCACATCTAC
GG 
TACCAGGTTGAAGGAGGG
GT 
NM_00110850
9.2  
EGR-1 CGAGCGAACAACCCTACG
A 
CGATGTCAGAAAAGGACT
CTGTG 
NM_012551.2  
FOXO-1 TGCAGCAGACACCTTGCT
AT 
TTGGGGCTGGGGGAATTT
AG 
NM_00119184
6.2 
IL-1β CAGCTTTCGACAGTGAGG
AGA 
GTCGAGATGCTGCTGTGA
GA 
NM_031512.2 
TNFα CCGGGCAGGTCTACTTTG
GA 
AGGCCACTACTTCAGCGT
CTCG 
NM_012675.3 
IL-6 CTTCCAGCCAGTTGCCTT
CTTG 
TGGTCTGTTGTGGGTGGT
ATCC 
NM_012589.2 
CD68 ACTGGGGCTCTTGGAAAC
TACAC 
CCTTGGTTTTGTTCGGGTT
CA 
NM_00103163
8.1 
SOD-1 ATTGGCCGTACTATGGTG
GTC 
GCAATCCCAATCACACCA
CA 
NM_017050.1  
SOD-2 ATTGCCGCCTGCTCTAAT
CA 
TCCCACACATCAATCCCC
AG 
NM_017051.2 
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Table 2. Western Blot antibodies, dilutions used in experiments, and company and catalogue 
information.  
Antibody name Source Dilution Company (#Catalogue) 
4-HNE Mouse 
monoclonal 
1:500 R&D Systems Minneapolis, MN, 
USA (#MAB3249)  
AKT-1 Rabbit 
polyclonal 
1:500 Abcam Inc., Cambridge, MA, 
USA (#abcam 5919) 
ATGL (H-144) Rabbit 
polyclonal 
1:1000 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-
67355) 
C/EBPα (14AA) Rabbit 
polyclonal 
1:500 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-61) 
C/EBPβ (C-19) Rabbit 
polyclonal 
1:300 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-150) 
SOD-1 (FL-154) Rabbit 
polyclonal 
1:1000 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-
11407) 
SOD-2 (FL-222) Rabbit 
polyclonal 
1:1000 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-
30080)  
SREBP 1c (H-160) Rabbit 
polyclonal 
1:500 Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA (#sc-8984) 
Mouse IgG (H+L) Secondary Sheep 1:5000 GE Healthcare UK, Pittsburgh, 
PA, USA (#NA931) 
Rabbit IgG (H+L) Secondary Donkey 1:10000 Jackson ImmunoResearch 
Laboratories, West Grove, PA, 
USA (#711-001-003) 
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